Euromonitor and PharmaLinea Reveal Nutraceutical Trends Projected for 2025
PharmaLinea, a private label manufacturer, and Euromonitor, a market research firm, recently conducted a webinar pointing out predicted trends that hold the potential to shape the nutraceuticals market globally by 2025.
The sector is continually progressing, focusing on producing goods that cater to particular chronic conditions and manage diverse treatment side effects, moving from a preventative approach to “during” and “post” care. The advent of new products underlines a growing emphasis on improving quality of life through specialized, clinically-verified solutions.
GLP-1 medications have made a swift difference in healthcare, with 12% of adults in the U.S. having used these drugs, as stated in a survey by the Kaiser Family Foundation. Simultaneously, the popularity of weight management supplements fell by 14% in 2024 according to SPINS, conversely, related markets like protein bars and multivitamins are on the upswing. Opportunity areas in this market are classified by the firms into three divisions.
Supplements for sexual health are seeing an upswing in consumer interest and a noticeable shortfall in service, as reported by the firms. While it is estimated that about 85% of EU consumers are receptive to the use of sexual health supplements, it often accounts for less than 5% of the overall market according to Euromonitor. To address this, engaging, stereotype-disrupting marketing strategies are required, particularly for women, along with scientific-based, efficient formulations.
These products are viewed favorably when linked with widespread benefits such as vitality, stress reduction, or menopausal support.
The cell health sector, revolving around NMN and NAD, is experiencing quick expansion worldwide. High-end products like TimeLine’s Mitopure and Maripolio’s Liposomal NAD+ are shipping approximately 7,000 units per month on Amazon, showing a robust demand despite the high price point. According to the firms, customers are enticed by the pledge of longevity and vitality, even without immediate results.
PharmaLinea claims that the industry is shifting its focus towards soft chews, a promising future delivery format, mainly due to their enhanced carrying capacity for active ingredients. Soft chews are also produced with lesser heat, maintaining ingredient reliability and power. Along with their functional quality, PharmaLinea suggests that they are seen as being more stylish and medicinal, attracting consumers seeking a blend of effectiveness and sophistication.
Concerning budding marketing strategies, both companies emphasized on three evolving trends: